response rate (complete and partial remissions, antileukemic effect) after four treatment courses of Decitabine, after 6 months [clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a]

response rate (complete and partial remissions, antileukemic effect) after four treatment courses of Decitabine, after 6 months [clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a]

Decitabine 15 mg/m2 i.v. - single arm
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a
Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia [clinicaltrials:NCT00866073]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

response rate (complete and partial remissions, antileukemic effect) after four treatment courses of Decitabine, after 6 months [clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a]

Decitabine 15 mg/m2 i.v. - single arm
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a
Bio2RDF identifier
000256a34aa461a70155e6c3b0a9414a
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a
measure [clinicaltrials_vocabulary:measure]
response rate (complete and partial remissions, antileukemic effect)
time frame [clinicaltrials_vocabulary:time-frame]
after four treatment courses of Decitabine, after 6 months
description
Decitabine 15 mg/m2 i.v. - single arm
identifier
clinicaltrials_resource:000256a34aa461a70155e6c3b0a9414a
title
response rate (complete and pa ...... of Decitabine, after 6 months
@en
inDataset
type
label
response rate (complete and pa ...... 256a34aa461a70155e6c3b0a9414a]
@en